PDSB
Closed
Pds Biotechnology Corp
1.22
-0.11 (-8.27%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 1.33
Day's Range: 1.205 - 1.3399
Send
sign up or login to leave a comment!
When Written:
5.81
PDS Biotechnology Corp is a clinical-stage biopharmaceutical company that develops immunotherapies for cancer and infectious diseases. The company's proprietary Versamune® platform technology is designed to activate and direct the immune system to attack specific cancer cells or infectious agents.
PDS Biotechnology Corp's lead product candidate, PDS0101, is being developed for the treatment of HPV-associated cancers and is currently in Phase 2 clinical trials. The company is also developing immunotherapies for other types of cancer, as well as infectious diseases such as COVID-19.
The company was founded in 2005 and is based in Princeton, New Jersey. It is publicly traded on the Nasdaq exchange under the ticker symbol "PDSB."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
PDS Biotechnology Corp's lead product candidate, PDS0101, is being developed for the treatment of HPV-associated cancers and is currently in Phase 2 clinical trials. The company is also developing immunotherapies for other types of cancer, as well as infectious diseases such as COVID-19.
The company was founded in 2005 and is based in Princeton, New Jersey. It is publicly traded on the Nasdaq exchange under the ticker symbol "PDSB."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








